U.S. drug giant Pfizer will invest $130 million upgrading two of its Irish plants to accommodate work on new drugs coming through its pipeline. The company announced yesterday it will invest $100 million at its biologics operation in Grange Castle, west Dublin, and a further $30 million at Ringaskiddy, Co Cork.
Manufacturing capacity at Grange Castle will be expanded with a new production line that will double production of its rheumatoid arthritis drug Enbrel. The expanded facility, which is due to be operational in 2015, will also allow Grange Castle to manufacture new biologics. The Ringaskiddy investment will develop specialist new capability to manufacture some of Pfizer’s newest medicines in cancer and other areas. Read more